Idiopathic intracranial hypertension.
The syndrome of intracranial hypertension without structural brain or cerebrospinal fluid abnormalities and without identifiable cause, now most appropriately termed idiopathic intracranial hypertension, was described over a century ago. Although the pathogenesis of this condition remains unknown, diagnostic and therapeutic developments during the past two decades have substantially advanced patient management.
Friedman
Deborah I
DI
Departments of Ophthalmology and Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. Deborah_Friedman@urmc.rochester.edu
Jacobson
Daniel M
DM
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D002557:Cerebrospinal Fluid Shunts; D019299:Decompression, Surgical; D004035:Diet Therapy; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D009900:Optic Nerve / Q000601:surgery; D011379:Prognosis; D011559:Pseudotumor Cerebri / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D013129:Spinal Puncture; D014785:Vision, Ocular
D000305:Adrenal Cortex Hormones; D002257:Carbonic Anhydrase Inhibitors; D004232:Diuretics